Non-contact monitoring to spot heart failure problems early
Official title: Commercialization of Non-contact Cardiopulmonary Monitoring for Heart Failure
Funded at Nightingale Labs Corporation · NIH-11323850 · Data updated 2026-11-12
A new, hands-off system uses bed sensors at home to continuously watch heart and lung signals so doctors can catch trouble before it leads to hospital visits.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nightingale Labs Corporation NIH-funded |
| Lab location | 1 site (Solana Beach, United States) |
| Project start | August 1, 2026 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $1,368,368 |
| NIH project number | 1R44HL184876-01 |
| Project ID | NIH-11323850 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with chronic heart failure who are at risk of decompensation and could benefit from continuous non-contact monitoring.
✕Less likely to help
Patients with no access to home bed sensor technology or who have conditions making non-contact monitoring impractical.
What this research studies
This project aims to help people with chronic heart failure by using automated bed sensors that don’t require patients to do anything special. The system monitors cardiopulmonary signals over time and flags when deterioration or recovery is detected, so clinicians can adjust treatment promptly. It builds on earlier Phase 1 work and plans to test in outpatient and inpatient settings, with plans for FDA 510(k) clearance. The goal is to keep patients safe at home and make managing heart failure more proactive and data-driven.
Why it matters
Potential benefit: If successful, patients could experience fewer hospitalizations and better at-home management of heart failure.
How similar studies have gone: Earlier work showed promise in automated deterioration detection using non-contact sensors, supporting further testing.
Where this research is happening
-
Nightingale Labs Corporation
Solana Beach, United States Active
Researchers
- Principal investigator: Chan, Raymond C — Nightingale Labs Corporation
- Study coordinator: Chan, Raymond C
Related research
Other NIH-funded projects on the same topics.
-
AI-supported heart failure diagnosis and management in Rwanda
Aiming to help people with suspected heart failure in Rwanda get faster, more accurate diagnoses and better care using AI-guided ultrasound and care protocols.
-
AI-assisted heart failure diagnosis in Rwanda using focused ultrasound
An NIH-funded project will test whether AI-enhanced, easy-to-use heart ultrasound can help non-experts diagnose and manage heart failure in Rwanda.
-
HF endotypes in heart failure using ethical multi-modal AI and molecular data
A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.
-
Triple gene therapy approach to heal the heart after a heart attack
A new therapy combines three genetic approaches delivered by a virus to help the heart heal after a heart attack.
-
Digital-first heart failure care delivery in Uganda
A targeted program in Uganda tests a digital care plan to help people with heart failure manage their symptoms at home.
-
Digital-first heart failure care delivery in Uganda
A study to test digital self-care tools to help people with heart failure in Uganda manage symptoms and stay healthier.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.